Orthocell Ltd is a regenerative medicine company dedicated to the development of novel collagen medical devices and cellular therapies for the repair and regeneration of bone and soft tissue defects.
Orthocell Ltd is a regenerative medicine company dedicated to the development of novel collagen medical devices and cellular therapies for the repair and regeneration of bone and soft tissue defects. The CelGro™ platform of collagen medical devices consist of Striate+™ for dental guided bone and tissue regeneration, Remplir™ for nerve repair* and SMRT Graft™ for tendon and ligament repair*.
Striate+™ is Orthocell’s flagship dental membrane used for guided bone and tissue regeneration procedures and is proudly Australian-designed and manufactured, with no crosslinking, using our proprietary SMRT™ manufacturing technology. Striate+™ is a premium bilayer resorbable collagen membrane with exceptional handling characteristics and osteoconductive properties that facilitates faster, better bone regeneration, providing dental surgeons with predictable outcomes.
*Orthocell’s nerve and tendon medical devices are currently not approved for supply in the U.S.
Striate+™ is more than a barrier membrane due to its:
Pure acellular collagen membrane with optimal integration profile
Exceptional handling properties
Flexible and easy to handle even when wet and can be used with or without pins and sutures
Optimal tissue integration and remodelling
Provides a favorable environment to promote rapid bone regeneration and high-quality tissue repair
"The one critical characteristic that is important for a barrier membrane is the handling property. It is up to the manufacturer to prove that the resorption rate and biocompatibility are worthy. But, if intraoperative handling is difficult, it simply cannot be put to good use. I find Striate+ membranes from Orthocell to be just that—excellent feel and ease of use, coupled with reliable research data to provide the clinician with trusted evidence. My clinical experience so far has been outstanding . . ."